Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.

Authors
Category Primary study
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2000
Because there is limited information about suppression of virus loads (determined by current "ultrasensitive" assays) in patients receiving nucleoside reverse-transcriptase inhibitors (NRTIs) alone, we reviewed our experience in clinical practice with patients who had virus loads of <25 copies/mL after >1 year of treatment with dual NRTIs.
Epistemonikos ID: 023fb4630cb24dc58dc4a69c5628691ae8645aa2
First added on: Dec 08, 2021